Daito Pharmaceutical Co (TSE:4577) Total Liabilities: 円24,639 Mil (As of Nov. 2025)


TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
78 GF Score
Price 円1,247.00
GF Value 円1,279.44
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Total Liabilities?

Daito Pharmaceutical Co TSE:4577 -0.16% 78 Total Liabilities is 円24,639 Mil as of Nov. 2025. GuruFocus rates TSE:4577 with a GF Score™ of 78/100 and a GF Value™ of 円1,279.44 (Fairly Valued). The stock has 3 warning signs investors should review.

Daito Pharmaceutical Co's Total Liabilities for the quarter that ended in Nov. 2025 was 円24,639 Mil.

Daito Pharmaceutical Co's quarterly Total Liabilities increased from May. 2025 (円25,937.00 Mil) to Aug. 2025 (円26,625.00 Mil) but then declined from Aug. 2025 (円26,625.00 Mil) to Nov. 2025 (円24,639.00 Mil).

Daito Pharmaceutical Co's annual Total Liabilities increased from May. 2023 (円19,581.00 Mil) to May. 2024 (円25,444.00 Mil) and increased from May. 2024 (円25,444.00 Mil) to May. 2025 (円25,937.00 Mil).

Daito Pharmaceutical Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Total Liabilities Chart

Daito Pharmaceutical Co Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,823.00 17,268.00 19,581.00 25,444.00 25,937.00

Daito Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25,015.00 25,937.00 26,625.00 24,639.00 22,629.00
TSE:4577
78GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Daito Pharmaceutical Co's Total Liabilities for the fiscal year that ended in May. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=17049+(8428+254
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+206+0)
=25,937

Total Liabilities=Total Assets (A: May. 2025 )-Total Equity (A: May. 2025 )
=78004-52067
=25,937

Daito Pharmaceutical Co's Total Liabilities for the quarter that ended in Nov. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=16551+(7594+269
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+225+0)
=24,639

Total Liabilities=Total Assets (Q: Nov. 2025 )-Total Equity (Q: Nov. 2025 )
=76842-52203
=24,639

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円24,639 Mil mean?
Daito Pharmaceutical Co (TSE:4577) has a Total Liabilities of 円24,639 Mil as of Nov. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Daito Pharmaceutical Co and its competitors.
Is Daito Pharmaceutical Co's Total Liabilities too high?
Daito Pharmaceutical Co's current Total Liabilities is 円24,639 Mil. Overall, Daito Pharmaceutical Co has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Total Liabilities compare to ZTS and UTHR?
Daito Pharmaceutical Co's Total Liabilities of 円24,639 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Daito Pharmaceutical Co and its competitors. Daito Pharmaceutical Co's current Total Liabilities is 円24,639 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,279.44, compared to a current price of 円1,247.00 — trading 2.5% below its estimated fair value. The current Total Liabilities is 円24,639 Mil. Daito Pharmaceutical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Total Liabilities is 円24,639 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,247.00 is trading 2.5% below its estimated GF Value™ of 円1,279.44. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Total Liabilities: 円24,639 Mil
  • GF Value™: 円1,279.44 vs. price of 円1,247.00 (2.5% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
78GF Score

Get the complete analysis for TSE:4577

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,247.00
Price
円1,279.44
GF Value